Your browser doesn't support javascript.
loading
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial.
Song, Andrew J; Ding, Keyue; Alnahhas, Iyad; Laperriere, Normand J; Perry, James; Mason, Warren P; Winch, Chad; O'Callaghan, Chris J; Menten, Johan J; Brandes, Alba A; Phillips, Claire; Fay, Michael F; Nishikawa, Ryo; Osoba, David; Cairncross, J Gregory; Roa, Wilson; Wick, Wolfgang; Shi, Wenyin.
Afiliação
  • Song AJ; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Ding K; Department of Public Health Sciences, Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.
  • Alnahhas I; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Laperriere NJ; Department of Radiation Oncology, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
  • Perry J; Department of Medicine, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
  • Mason WP; Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Winch C; Department of Public Health Sciences, Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.
  • O'Callaghan CJ; Department of Public Health Sciences, Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.
  • Menten JJ; Department of Experimental Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Brandes AA; Department of Medical oncology, IRCCS Istituto Scienze Neurologiche - Bologna, Italy.
  • Phillips C; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Fay MF; Genesis Cancer Care, Newcastle, NSW, Australia.
  • Nishikawa R; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Osoba D; QOL Consulting, West Vancouver, British Columbia, Canada.
  • Cairncross JG; Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
  • Roa W; Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Wick W; Division of Neurology, Heidelberg University Medical Center, Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
  • Shi W; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Neurooncol Adv ; 4(1): vdac011, 2022.
Article em En | MEDLINE | ID: mdl-35098127
[This corrects the article DOI: 10.1093/noajnl/vdab153.].
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article